Thermo Fisher to ac­quire ad­vanced bio­pro­cess­ing biz from BD

BioSpectrum (India) - - SUPPLIER NEWS -

Thermo Fisher Sci­en­tific Inc. has signed a de­fin­i­tive agree­ment with BD (Bec­ton, Dick­in­son and Com­pany), a lead­ing global med­i­cal tech­nol­ogy com­pany, un­der which Thermo Fisher will ac­quire BD’s Ad­vanced Bio­pro­cess­ing busi­ness. This busi­ness com­bines a strong tech­ni­cal ser­vices pro­gram with a va­ri­ety of pep­tones that en­hance cell cul­ture me­dia for­mu­la­tions to im­prove yield and re­duce vari­abil­ity in bio­phar­ma­ceu­ti­cal ap­pli­ca­tions.

BD’s Ad­vanced Bio­pro­cess­ing busi­ness has an­nu­al­ized rev­enue of ap­prox­i­mately $100 mil­lion and will be in­te­grated into Thermo Fisher’s Life Sciences So­lu­tions Seg­ment. The trans­ac­tion is sub­ject to cus­tom­ary clos­ing con­di­tions and is ex­pected to close in early 2019.

BD Ad­vanced Bio­pro­cess­ing in­cludes cell cul­ture me­dia, sup­ple­ments, and feeds de­signed to work in a va­ri­ety of bio­phar­ma­ceu­ti­cal ap­pli­ca­tions in­clud­ing the pro­duc­tion of vac­cines, mon­o­clonal an­ti­bod­ies, and biosim­i­lars, with the goals of im­prov­ing yield and re­duc­ing vari­abil­ity.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.